TrialFinder  /  Landscape Report ANOREXIA  ·  2026-10-26 Revasser  /  revasserkernel.com
Landscape Report TrialFinder
SOURCE  ClinicalTrials.gov API v2
GENERATED  2026-10-26
VERSION  v1
SAMPLE  100 of 7445 studies

anorexia

The anorexia clinical trial landscape includes 7445 actively recruiting trials. Semantic expansion identified 7350 additional trials beyond exact-match search, representing a 7736.8% discovery lift across related conditions and therapeutic approaches.

Recruiting
7445
active trials
Expansion Lift
+7736.8%
7350 additional trials
Top Sponsor
Massachusetts General Hospital
4 trials
Dominant Phase
NA
64 of 102 sampled
Pipeline Overview
Phase Distribution
NA
64
Phase 1
4
Phase 2
9
Phase 3
1
Phase 4
5
Other
19
Therapeutic Modalities
BEHAVIORAL
57
DRUG
33
DEVICE
27
OTHER
24
PROCEDURE
9
DIAGNOSTIC_TEST
7
DIETARY_SUPPLEMENT
3
COMBINATION_PRODUCT
1
Recruiting vs. Completed (2yr)
Recruiting
7445
Completed
4941
Competitive Landscape
Sponsor Classification
70%
15%
15%
OTHER (19)
FED (4)
NIH (4)
Top Sponsors
SponsorTrialsClass
Massachusetts General Hospital4OTHER
VA Office of Research and Development3FED
Stanford University3OTHER
Centre for Addiction and Mental Health2OTHER
National Institute of Mental Health (NIMH)2NIH
University of California, Los Angeles2OTHER
National Institute on Drug Abuse (NIDA)2NIH
Medical University of South Carolina2OTHER
VA Boston Healthcare System1FED
University Hospital of Patras1OTHER
Florida State University1OTHER
University Hospital, Montpellier1OTHER
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization1OTHER
St. Joseph's Healthcare Hamilton1OTHER
University of Regina1OTHER
Geographic Distribution
Top U.S. States by Trial Density
StateTrialsTop City
Florida17Miami
California17Los Angeles
Massachusetts6Boston
Maryland6Baltimore
Georgia6Atlanta
South Carolina5Charleston
Texas5Austin
Ohio4Columbus
Michigan4Lansing
Illinois4Chicago
Pennsylvania3Philadelphia
Arkansas3Jonesboro
Virginia2Fairfax
New York2Valhalla
Minnesota2Rochester
Connecticut1New Haven
North Carolina1Denver
Missouri1Columbia
Alabama1Birmingham
Indiana1Indianapolis
Expansion Intelligence
+7736.8%
Discovery lift — trials found by semantic expansion that exact-match search misses entirely. This is the gap competitors don't see.
2
Exact
2
Parent
3
Related
5
Comorbid
4
Therapeutic
Top Expansion Terms
  • eating disorder Parent
  • psychiatric disorder Parent
  • bulimia nervosa Related
  • binge eating disorder Related
  • ARFID Related
  • depression Comorbid
  • anxiety Comorbid
  • osteoporosis Comorbid
  • amenorrhea Comorbid
  • cardiac arrhythmia Comorbid

These terms are curated from clinical literature — not generated by a language model. Each captures trials that use variant nomenclature for the same underlying condition or therapeutic area.

Key Findings
What This Landscape Means for anorexia
high
Standard searches miss 7737% of relevant trials for anorexia — semantic expansion across related conditions and therapeutic approaches is essential for complete landscape visibility.
7350 additional trials found via expansion vs 95 exact matches
high
Phase 2 volume (9) significantly exceeds Phase 3 (1), indicating a pipeline bottleneck — most candidates are 2-4 years from potential approval.
Phase 2/Phase 3 ratio: 9.0x
Next Steps
Take Action on This Intelligence
//
Stay Current
Get alerted when new trials open for anorexia and related conditions. Free tier monitors 1 condition weekly.
Set Up Alerts
[+]
Research Portal
Deploy this intelligence as your organization's permanent research hub — auto-updating, branded, zero hosting cost.
From $497
{<}
API Access
Integrate trial intelligence into your own tools. Full expansion engine, landscape analytics, real-time data.
View Plans
Top Recruiting Trials
20 actively recruiting studies
Mechanisms Underlying the Efficacy of Prolonged Exposure
VA Boston Healthcare System n=50 VA Boston Healthcare System Boston, Massachusetts
Intervention BEHAVIORAL: Prolonged Exposure Therapy for Posttraumatic Stress Disorder — Participation will occur throughout 17 weeks over 15 separate visits during which 10, 60-minute sessions of PE will take...
Eligibility Ages 18 Years – 90 Years
Contact Suzanne Pineles, PhD · 857-364-5906 · suzanne.pineles@va.gov
Left Bundle Branch Pacing vs Right Ventricular Pacing on AHRE Burden in Patients With Preserved LVEF
University Hospital of Patras n=244 University General Hospital of Patras Pátrai
Intervention DEVICE: Right Ventricular Pacing — Implantation of a dual-chamber pacemaker with the ventricular lead placed in the RV septum. At follow-up, the ventricul...
Eligibility Ages 18 Years
Contact GEORGIOS LEVENTOPOULOS · +306977786020 · levent2669@gmail.com
Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression
Florida State University n=72 Florida State University Tallahassee, Florida
Intervention DEVICE: Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4 — Stimulation will be delivered via the Neurocare Direct Current Stimulator Multi-Channel 4, an investigational electrical...
Eligibility Ages 18 Years – 65 Years
Contact Justin M Riddle, PhD · 850-645-2389 · jriddle@fsu.edu
NCT05515354 PHASE4
Smoking Cessation and Menstrual Cycle Phase
Centre for Addiction and Mental Health n=1200 Centre for Addiction and Mental Health, Nicotine Dependence Clinic Toronto, Ontario
Intervention OTHER: Timing of nicotine replacement therapy start date — Nicotine replacement therapy and abstinence from smoking are initiated at a specific period with regard to the menstrual...
Eligibility Ages 18 Years – 40 Years, FEMALE only
Contact Laurie A Zawertailo, PhD · 4165358501 · laurie.zawertailo@camh.ca
NCT05336695 PHASE1, PHASE2
Assess Fibrin in Brains With AD/ADRD
Massachusetts General Hospital n=30 Massachusetts General Hospital Boston, Massachusetts
Intervention DIAGNOSTIC_TEST: PET/MR Imaging — PET/MRI Scan with \[64Cu\]FBP8 as directed by protocol
Eligibility Ages 55 Years – 90 Years
Contact Ciprian Catana, MD, PhD · 617-643-4885 · ccatana@mgh.harvard.edu
NCT05681572 PHASE3
Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia
University Hospital, Montpellier n=1000 Uhmontpellier Montpellier, Montpellier
Intervention DRUG: Midazolam — 45 minutes before entering the operating room, patient receives the oral treatment according to their randomization arm,...
Eligibility Ages 7 Years – 18 Years
Contact Sophie BRINGUIER, PHD · 0467338661 · s-bringuierbranchereau@chu-montpellier.fr
Analgesia Methods and Early Mobilization in Geriatric ICU Patients After Major Surgery
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization n=90 University of Health Sciences, Prof. Dr. Cemil Taşçıoğlu City Hospital Istanbul, Istanbul
Intervention DRUG: Systemic Opioid Analgesia (± Multimodal) — Standard-of-care intravenous opioid-based analgesia, with or without additional non-opioid multimodal agents, administer...
Eligibility Ages 65 Years
Contact Zekeriya Ervatan, MD · +90505 598 32 48 · zek.ervatan@gmail.com
Psychological and Physiological Impact of a Mindfulness-based Intervention on Anxiety Disorders During the Postpartum Period
St. Joseph's Healthcare Hamilton n=50 Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton Hamilton, Ontario
Intervention BEHAVIORAL: 4-week mindfulness-based intervention — This is the first mindfulness-based intervention specifically designed for postpartum mothers and birthing parents with ...
Eligibility Ages 18 Years, FEMALE only
Contact Sheryl M Green, Ph.D., C.Psych · 905-522-1155 · sgreen@stjosham.on.ca
The PSP Sleep Course: An Online Sleep Intervention for Public Safety Personnel With Self-reported Sleep Difficulties.
University of Regina n=60 University of Regina Regina, Saskatchewan
Intervention BEHAVIORAL: Sleep Course — The Sleep Course was previously developed and evaluated in Australia and has since been tailored to Canadian public safe...
Eligibility Ages 18 Years
Contact Heather D Hadjistavropoulos, PhD · 306-585-5133 · heather.hadjistavropoulos@uregina.ca
An Ethical Approach to Detecting Covert Consciousness
Massachusetts General Hospital n=70 Massachusetts General Hospital Boston, Massachusetts
Intervention OTHER: Clinician Questionnaire — Surveys will serve to identify preferences, expectations and concerns among clinicians and researchers surrounding data-...
Eligibility Ages 18 Years
Contact Michael Young, MD · 617-724-6352 · Michael.Young@MGH.HARVARD.EDU
NCT04396873 PHASE1
PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
National Institute of Mental Health (NIMH) n=184 National Institutes of Health Clinical Center Bethesda, Maryland
Intervention DRUG: 11C-MC1 — Injected IV followed by PET scanning
Eligibility Ages 18 Years – 99 Years
Contact Tara N Turon, C.R.N.P. · (301) 827-6599 · tara.turon@nih.gov
Social Information Processing in Children: an ocUlo-pupillometric Tool for Standard Evaluation
University Hospital, Tours n=460 Service de Pédopsychiatrie-CHU-TOURS Tours
Intervention OTHER: eye-tracker — Eye-tracker recordings of eye movements, gaze direction and pupillary reactivity
Eligibility Ages 1 Day – 50 Years
Contact Nadia Aguillon-Hernandez, MCU · 0247478840 · nadia.aguillon@univ-tours.fr
NCT06194851 PHASE2
Examining Intranasal Oxytocin Augmentation of Brief Couples Therapy for Veterans With PTSD
VA Office of Research and Development n=240 VA San Diego Healthcare System, San Diego, CA San Diego, California
Intervention DRUG: Oxytocin nasal spray — Veteran participants will self-administer 40 IU of intranasal oxytocin 30 minutes before the start of each bCBCT session...
Eligibility Ages 18 Years
Contact Leslie A Morland, PsyD · (619) 497-8406 · Leslie.Morland@va.gov
Peer Facilitated Waitlist Controlled Transportation Study
Temple University n=180 Pathways To Housing PA Philadelphia, Pennsylvania
Intervention BEHAVIORAL: Bike-Share Travel Training — Half of the participants not assigned to the waitlist will begin the bike-share intervention arm immediately after the b...
Eligibility Ages 18 Years – 65 Years
Contact Gillian A MacDonald, BA · ‪(267) 225-0218‬ · gillian.macdonald@temple.edu
Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders
University Hospital, Grenoble n=100 Grenoble Grenoble
Eligibility Ages 18 Years
Contact Cécile BERTY · 0476765509 · CBetry@chu-grenoble.fr
Evaluation of the Role of Luteinizing Hormone (LH) and Human Chorionic Gonadotropin (hCG) in Adult Patients Undergoing Assessment for Endocrine Disorders
Martin Blomberg Jensen n=20000 Department of Endocrinology and Internal Medicine, Herlev Hospital Herlev
Eligibility Ages 18 Years – 90 Years
Contact Martin B Jensen, Professor · +4538687318 · martin.blomberg.jensen@regionh.dk
NCT07027839 PHASE1
Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)
National Institute of Mental Health (NIMH) n=30 National Institutes of Health Clinical Center Bethesda, Maryland
Intervention DRUG: Intravenous Ethanol — Intravenous ethanol infusion before PET Scan
Eligibility Ages 21 Years – 70 Years
Contact Tara N Turon, C.R.N.P. · (301) 827-6599 · tara.turon@nih.gov
Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
University of Southern California n=140 University of Southern California Los Angeles, California
Intervention BEHAVIORAL: Explicit CBT SAR Personalization for 6 weeks — College student participants with clinically elevated anxiety will engage in 6 weeks of in-home CBT daily exercises with...
Eligibility Ages 18 Years
NCT06511011 PHASE2
Chinese Medicine in Treating Insomnia
Chinese University of Hong Kong n=76 Hong Kong Institute of Integrative Medicine Shatin
Intervention DRUG: Modified Suan ZaoRen Tang-TianWang BuXin Dan — Chinese medicine granules for 6 weeks
Eligibility Ages 18 Years – 65 Years
Contact Zhixiu Lin · 39436347 · linzx@cuhk.edu.hk
Recovery With Exogenous Ketones and Antipsychotics
Université de Sherbrooke n=15 Hotel-Dieu CIUSSS de l'Estrie-CHUS Sherbrooke, Quebec
Intervention OTHER: Medium chain triglyceride oil — Supplementation with 15 g of medium chain triglyceride oil, a food product commercially available over-the-counter in re...
Eligibility Ages 18 Years – 35 Years
Contact Melanie Fortier, M.Sc · 1-819-821-5206 · melanie.fortier2@usherbrooke.ca